INFANRIX DTPa-IPV+Hib susp inj (n ser pré) 0.5 ml
7680006190030
Pharmacode 1108357
CH-619
J07CA06
08.08.
Active substances:
1 / 2
google
Details
- GTIN
- 7680006190030
- Pharmacode
- 1108357
- Product number
- 0061901
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- I) DTPa-IPV: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U., aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, polysorbatum 80, formaldehydum. II) Hib: polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, lactosum, pro praeparatione. I) et II) corresp. DTPa-IPV + Hib: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U., polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 1.8 mg, medium 199, lactosum, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, polysorbatum 80, formaldehydum.
Articles (1)
Infanrix DTPa-IPV+Hib, Pulver und Suspension zur Herstellung einer Injektionssuspension
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
toxoidum diphtheriae
|
- | Substance | Wirkstoff (Principe actif) |
|
polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
toxoidum diphtheriae
|
- | Substance | Wirkstoff (Principe actif) |
|
toxoidum tetani
|
- | Substance | Wirkstoff (Principe actif) |
|
lactosum
|
- | Substance | HNIDK |
|
toxoidum tetani
|
- | Substance | Wirkstoff (Principe actif) |
|
toxoidum pertussis
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
toxoidum pertussis
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum filamentosum
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum filamentosum
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
pertactinum
|
8.0 UG | Substance | Wirkstoff (Principe actif) |
|
pertactinum
|
8.0 UG | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 1 inactivatus
|
40.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 1 inactivatus
|
40.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 2 inactivatus
|
8.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 2 inactivatus
|
8.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 3 inactivatus
|
32.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 3 inactivatus
|
32.0 U | Substance | Wirkstoff (Principe actif) |
|
polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
aluminium
|
0.5 MG | Substance | HBESI |
|
aluminium
|
0.5 MG | Substance | HBESI |
|
aluminii hydroxidum hydricum ad adsorptionem
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
aluminii hydroxidum hydricum ad adsorptionem
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrium
|
1.8 MG | Substance | HBESI |
|
medium 199
|
- | Substance | HNIDK |
|
natrium
|
1.8 MG | Substance | HBESI |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
medium 199
|
- | Substance | HNIDK |
|
lactosum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
neomycini sulfas
|
- | Substance | RESI |
|
polymyxini B sulfas
|
- | Substance | RESI |
|
neomycini sulfas
|
- | Substance | RESI |
|
polysorbatum 80
|
- | Substance | RESI |
|
formaldehydum
|
- | Substance | RESI |
|
polymyxini B sulfas
|
- | Substance | RESI |
|
polysorbatum 80
|
- | Substance | RESI |
|
formaldehydum
|
- | Substance | RESI |
Reimbursement information
Public price
CHF 52.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1999
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 619
- Drug name
- Infanrix DTPa-IPV+Hib, Pulver und Suspension zur Herstellung einer Injektionssuspension
- Galenic form
- PULSIN
- ATC Code
- J07CA06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/09/1998
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- INFANRIX DTPa-IPV+Hib susp inj (n ser pré) 0.5 ml
- Description (DE)
- INFANRIX DTPa-IPV+Hib Inj Susp (n Fertspr) 0.5 ml
- Market launch
- 29/09/1998
- Narcotic (BTM)
- No
Application methods
IMU